Lv41
490 积分 2024-05-29 加入
Pharmacokinetic and Pharmacodynamic Properties of Meropenem
1个月前
已完结
Maintenance of Lost Weight and Long-Term Management of Obesity
3个月前
已完结
Tirzepatide for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled trial
3个月前
已完结
A randomized phase I study of BI 1820237, a novel neuropeptide Y receptor type 2 agonist, alone or in combination with low‐dose liraglutide in otherwise healthy men with overweight or obesity
3个月前
已完结
Practical guide to concentration-QTc modeling: a hands-on tutorial
4个月前
已完结
Tirzepatide for Weight Reduction in Chinese Adults With Obesity
6个月前
已完结
A model‐based approach to predict individual weight loss with semaglutide in people with overweight or obesity
8个月前
已完结
Pharmacokinetic and pharmacodynamic bioequivalence of Gan & Lee insulin analogues aspart (rapilin®), lispro (prandilin®) and glargine (basalin®) with EU ‐ und US‐sourced reference insulins
8个月前
已完结
Individual‐Specific QT Interval Correction for Drugs With Substantial Heart Rate Effect Using Holter ECGs Extracted Over a Wide Range of Heart Rates
9个月前
已完结
A New QT Interval Correction Formulae to Adjust for Increases in Heart Rate
10个月前
已完结
皖公网安备34019202002308
